Pituitary adenylate cyclase-activati ng polypeptide stimulates corticotropin-releasing factor , vasopressin and interleukin-6 gene transcription in hypothalamic 4 B cells

Corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) are the two major regulatory peptides in the hypothalamic–pituitary–adrenal axis. CRF, produced in the hypothalamic paraventricular nucleus (PVN) in response to stress, is secreted into the pituitary portal circulation, resulting in the release of adrenocorticotropic hormone from the anterior pituitary. AVP is synthesized in the PVN and supraoptic nucleus by various stressors. Hypothalamic 4B cells coexpress CRF and AVP. In 4B cells transfected with either a CRF or an AVP promoter-luciferase construct, forskolin increased the transcriptional activity of CRF or AVP. In the present study, we tried to determine whether pituitary adenylate cyclase-activating polypeptide (PACAP) regulates both CRF and AVP genes in the hypothalamic cells, because receptors for PACAP were expressed in the hypothalamic Journal of Endocrinology (2007) 195, 199–211 0022–0795/07/0195–199 q 2007 Society for Endocrinology Printed in Great cells. PACAP stimulated activity of both CRF and AVP promoter via protein kinase A pathway. PACAP stimulated interleukin (IL)-6 promoter activity and the levels of IL-6 mRNA and protein. IL-6 stimulated activity of both CRF and AVP promoter in a dose-dependent manner. Finally, we found that the stimulatory effects of PACAP on both activities were significantly inhibited by treatment with anti-IL-6 monoclonal antibody. These data suggest that PACAP is involved in regulating the synthesis of IL-6 mRNA and IL-6 protein, and that the increase in endogenous IL-6 also contributes to stimulate the expression of both CRF and AVP genes. Taken together, these findings indicate that PACAP stimulates the transcription of CRF, AVP, and IL-6 genes in hypothalamic 4B cells. Journal of Endocrinology (2007) 195, 199–211

[1]  Y. Oiso,et al.  Identification of a functional AP1 element in the rat vasopressin gene promoter. , 2006, Endocrinology.

[2]  T. González-Hernández,et al.  Interleukin-6 and Nitric Oxide Synthase Expression in the Vasopressin and Corticotrophin-releasing Factor Systems of the Rat Hypothalamus , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  P. Sassone-Corsi,et al.  Inhibition of Corticotrophin‐Releasing Hormone Transcription by Inducible cAMP‐Early Repressor in the Hypothalamic Cell Line, 4B , 2006, Journal of neuroendocrinology.

[4]  L. Halvorson,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. , 2005, Brain research. Molecular brain research.

[5]  A. Dunn.  Interleukin-6 access to the axis. , 2004, Endocrinology.

[6]  Andrew H. Miller,et al.  Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. , 2004, Endocrinology.

[7]  F. Vandesande,et al.  The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis , 1977, Cell and Tissue Research.

[8]  E. Motomura,et al.  Effects of odorants on the hypothalamic-pituitary-adrenal axis and interleukin-6 (IL-6) and IL-6 receptor mRNA expression in rat hypothalamus after restraint stress. , 2003, Chemical senses.

[9]  David Murphy,et al.  Microarray Analysis Reveals Interleukin-6 as a Novel Secretory Product of the Hypothalamo-neurohypophyseal System* , 2003, Journal of Biological Chemistry.

[10]  T. Rizvi,et al.  Corticotropin‐Releasing Hormone (CRH) Expression and Protein Kinase A Mediated CRH Receptor Signalling in an Immortalized Hypothalamic Cell Line , 2003, Journal of neuroendocrinology.

[11]  V. Manganiello,et al.  Cyclic adenosine 3',5'-monophosphate regulation of corticotropin-releasing hormone promoter activity in AtT-20 cells and in a transformed hypothalamic cell line. , 2003, Endocrinology.

[12]  J. Herman,et al.  In vitro regulation of corticotropin-releasing hormone. , 2003, Life sciences.

[13]  A. Arimura,et al.  Dopamine- and cyclic AMP-regulated phosphoprotein-immunoreactive neurons activated by acute stress are innervated by fiber terminals immunopositive for pituitary adenylate cyclase-activating polypeptide in the extended amygdala in the rat , 2002, Regulatory Peptides.

[14]  A. J. McArthur,et al.  Identification of PAC1 receptor isoform mRNAs by real-time PCR in rat suprachiasmatic nucleus. , 2002, Brain research. Molecular brain research.

[15]  T. Baumann,et al.  Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat. , 2002, Brain research. Molecular brain research.

[16]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[17]  K. Karalis,et al.  Corticotropin-releasing hormone regulates IL-6 expression during inflammation. , 2001, The Journal of clinical investigation.

[18]  H. Gainer,et al.  Gene regulation in the magnocellular hypothalamo-neurohypophysial system. , 2001, Physiological reviews.

[19]  Y. Ueta,et al.  Effects of Centrally Administered Pituitary Adenylate Cyclase-Activating Polypeptide on c-fos Gene Expression and Heteronuclear RNA for Vasopressin in Rat Paraventricular and Supraoptic Nuclei , 1999, Neuroendocrinology.

[20]  S. Rivest,et al.  Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. , 1999, Endocrinology.

[21]  A. Turnbull,et al.  Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. , 1999, Physiological reviews.

[22]  S. Rawlings,et al.  International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. , 1998, Pharmacological reviews.

[23]  J. Hannibal,et al.  Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat , 1998, Neuroscience Letters.

[24]  V. Grinevich,et al.  Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus , 1997, Brain Research.

[25]  S. Shioda,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP): a novel regulator of vasopressin-containing neurons , 1997, Brain Research.

[26]  S. Shioda,et al.  Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain , 1997, Neuroscience Research.

[27]  Y. Oiso,et al.  Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. , 1997, Endocrinology.

[28]  Y. Ouchi,et al.  Identification of arginine vasopressin mRNA in rat aortic smooth muscle cells. , 1997, Biochemical and biophysical research communications.

[29]  Louis J. Muglia,et al.  CRH and the immune system , 1997, Journal of Neuroimmunology.

[30]  H. Neumann,et al.  Major Histocompatibility Complex (MHC) Class I Gene Expression in Single Neurons of the Central Nervous System: Differential Regulation by Interferon (IFN)-γ and Tumor Necrosis Factor (TNF)-α , 1997, The Journal of experimental medicine.

[31]  Y. Ueta,et al.  PACAP type I receptor gene expression in the paraventricular and supraoptic nuclei of rats , 1996, Neuroreport.

[32]  H. Piggins,et al.  Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat , 1996, The Journal of comparative neurology.

[33]  T. Suda,et al.  Major role of 3',5'-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivo. , 1996, Endocrinology.

[34]  P. J. Larsen,et al.  Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress. , 1995, Endocrinology.

[35]  J. Loeffler,et al.  Pituitary adenyl cyclase-activating peptide: a hypophysiotropic factor that stimulates proopiomelanocortin gene transcription, and proopiomelanocortin-derived peptide secretion in corticotropic cells. , 1994, Neuroendocrinology.

[36]  G. Chrousos,et al.  Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. , 1994, The Journal of clinical endocrinology and metabolism.

[37]  Q. Huang,et al.  Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. , 1994, Neuroimmunomodulation.

[38]  B. Rabin,et al.  Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. , 1993, Endocrinology.

[39]  M. Whitnall.  Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system , 1993, Progress in Neurobiology.

[40]  K. Takahashi,et al.  Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. , 1993, Neuroendocrinology.

[41]  F. Holsboer,et al.  Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. , 1992, Molecular endocrinology.

[42]  A. Grossman,et al.  Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. , 1991, Endocrinology.

[43]  N. Minamino,et al.  Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). , 1990, Biochemical and biophysical research communications.

[44]  M. Culler,et al.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.

[45]  P. Heinrich,et al.  Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes , 1989, FEBS letters.

[46]  R. Thompson,et al.  Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. , 1988, Molecular endocrinology.

[47]  T. Suda,et al.  In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. , 1985, Life sciences.

[48]  G. Gillies,et al.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin , 1982, Nature.

[49]  E. Wecker,et al.  Replacement of T-cell function by a T-cell product. , 1972, Nature: New biology.